Pure Global

Steady Blood Glucose Monitoring System - Taiwan Registration 41f9eb919a7fcfcfffb36ab0348bd06f

Access comprehensive regulatory information for Steady Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 41f9eb919a7fcfcfffb36ab0348bd06f and manufactured by Flextronics Industrial (Shenzhen) Co., Ltd;; LifeScan Europe GmbH. The authorized representative in Taiwan is DKSH TAIWAN LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
41f9eb919a7fcfcfffb36ab0348bd06f
Registration Details
Taiwan FDA Registration: 41f9eb919a7fcfcfffb36ab0348bd06f
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Steady Blood Glucose Monitoring System
TW: ็ฉฉ็ฟ่‡ณๅฎ‰่ก€็ณ–็›ฃๆธฌ็ณป็ตฑ
Risk Class 2

Registration Details

41f9eb919a7fcfcfffb36ab0348bd06f

DHA09200128109

Company Information

Product Details

Used to quantitatively measure glucose (blood glucose) in fresh microvascular whole blood samples taken from fingertips. This system is intended for use by a single patient only and should not be shared. The system is designed to provide in vitro measurement of blood glucose concentrations in the home of diabetics (for in vitro diagnostics) and can also be used by healthcare professionals in clinical settings to assist in monitoring the effectiveness of diabetes control. This system is not intended for the diagnosis or screening of diabetes, nor is it intended for use in newborns.

A Clinical chemistry and clinical toxicology

A.1345 Glucose Test System

Input;; QMS/QSD;; Chinese goods;; Contract manufacturing

Dates and Status

Aug 24, 2021

Feb 02, 2028